S146L in MYC is a context-dependent activating substitution in cancer development.

Hinds, John W; Feris, Edmond J; Wilkins, Owen M; Deary, Luke T; Wang, Xiaofeng; Cole, Michael D

Hinds, John W; Feris, Edmond J; Wilkins, Owen M; Deary, Luke T; Wang, Xiaofeng; Cole, Michael D.

Afiliação

Hinds JW; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, Unites States of America.
Feris EJ; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, Unites States of America.
Wilkins OM; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, Unites States of America.
Deary LT; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, Unites States of America.
Wang X; Center for Quantitative Biology (CQB), Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, Unites States of America.
Cole MD; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, Unites States of America.

PLoS One ; 17(8): e0272771, 2022.

Article em En | MEDLINE | ID: mdl-36018850

Assuntos

Neoplasias; Proteínas Proto-Oncogênicas c-myc; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-myc / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google